Should Total Number of Lymph Nodes be Used as a Quality of Care Measure for Stage III Colon Cancer?
Cancer Survival
Log-rank test
DOI:
10.1097/sla.0b013e318197f2c8
Publication Date:
2009-05-21T10:15:26Z
AUTHORS (7)
ABSTRACT
In Brief Objective: To assess whether TNODS is an independent prognostic factor after adjusting for the lymph node ratio (LNR). Summary Background Data: The medical literature has suggested that associated with better survival in stage II and III colon cancer. Thus was endorsed as a quality measure patient care by American College of Surgeons, National Quality Forum. There is, however, little biologic rationale to support this linkage. Methods: A total 24,477 cancer patients were identified from Surveillance, Epidemiology, End Results registry categorized into 4 groups, LNR1 LNR4, according LNR interval: <0.07, 0.07 0.25, 0.25 0.50, >0.50. Patients also stratified high (≥12) low (<12) groups. method Kaplan-Meier used estimate 5-year log-rank test difference among different Results: have compared those (5-year 51.0% vs. 45.0%, P < 0.0001). However, stratifying status, there no significant between within strata LNR2 56.3% 56.0%, = 0.26). Ironically, had significantly worse than LNR3 41.2% 47.4%, 0.0009) 22.0% 32.1%, Conclusions: previously reported effect on node-positive confounded LNR. This observation calls question use patients' care. well-documented association number nodes examined (TNODS) outcome ratio.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (38)
CITATIONS (65)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....